Profound Medical - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeProfound Medical
Profound Medical logo

Profound Medical

0 followers

PRN

Performance

About Profound Medical

Profound Medical develops incision-free ablation therapies for urological conditions, focusing on transurethral ultrasound ablation for the prostate. Their TULSA-PRO system offers MRI-guided, real-time controlled ablation to treat localized prostate cancer, obstructive BPH, and other prostate diseases. The company emphasizes patient-centric, precise, and durable outcomes with regulatory clearances in major markets, and provides physician education and clinical publications to support adoption. Headquartered with operations in North America, it serves medical professionals and patients seeking minimally invasive prostate therapies.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Mathieu Burtnyk

Chief Operating Officer

Tom Tamberrino

Chief Commercial Officer

Rashed Dewan

Chief Financial Officer

Arun Menawat

Chairman and CEO

Key Facts

HQ Location

Mississauga, Canada

Founded

2008

Employees

51 - 200

Status

Public

Website

https://profoundmedical.com